Neostigmine with glycopyrrolate does not increase the incidence or severity of postoperative nausea and vomiting in outpatients undergoing gynaecological laparoscopy.
We studied 100 healthy women undergoing outpatient gynaecological laparoscopy in a randomized, double-blind and placebo-controlled study to evaluate the effect of neostigmine on postoperative nausea and vomiting (PONV). After induction of anaesthesia with propofol, anaesthesia was maintained with sevoflurane and 66% nitrous oxide in oxygen. Mivacurium was used for neuromuscular block. At the end of anaesthesia, neostigmine 2.0 mg and glycopyrrolate 0.4 mg, or saline, was given i.v. The incidence of PONV was evaluated in the postanaesthesia care unit, on the ward and at home. The severity of nausea and vomiting, worst pain, antiemetic and analgesic use, times to urinary voiding and home readiness were recorded. During the first 24 h after operation, 44% of patients in the neostigmine group and 43% in the saline group did not have PONV. We conclude that neostigmine with glycopyrrolate did not increase the occurrence of PONV in this patient group.
Nelskylä
K
K
Department of Obstetrics and Gynaecology, Helsinki University Central Hospital.
Yli-Hankala
A
A
Soikkeli
A
A
Korttila
K
K
D000328:Adult; D000556:Ambulatory Surgical Procedures; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006024:Glycopyrrolate / Q000009:adverse effects*; D006801:Humans; D007546:Isoquinolines / Q000037:antagonists & inhibitors; D010535:Laparoscopy; D000077590:Mivacurium; D009388:Neostigmine / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D010276:Parasympatholytics / Q000009:adverse effects*; D020250:Postoperative Nausea and Vomiting / Q000139:chemically induced*
D002800:Cholinesterase Inhibitors; D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D010276:Parasympatholytics; D009388:Neostigmine; D000077590:Mivacurium; D006024:Glycopyrrolate